Cynthia L. Toze

Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation

Thomas J. Nevill, Henry C. Fung, John D. Shepherd et al. · Blood · 1998 · 161 citations

Medicine, Genetics, Hematology +14

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

Ana Rio‐Machín, Tom Vulliamy, Nele Hug et al. · Nature Communications · 2020 · 116 citations · Full text

Life Sciences, Genetics, Hematology +17

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial

Irwin Walker, Tony Panzarella, Stephen Couban et al. · The Lancet Haematology · 2020 · 96 citations

Life Sciences, Hematology, Immunology +12

Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center

Shruthi Ganeshappa Kodad, Heather J. Sutherland, Wasithep Limvorapitak et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 19 citations

Medicine, Oncology, Surgery +16

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Irwin Walker, Kirk R. Schultz, Cynthia L. Toze et al. · Blood · 2014 · 16 citations

Life Sciences, Hematology, Immunology +14